SELLAS Life Sciences Group, Inc.

SLS stock score: 48/100

$11.35 · -6.51% · Scored Oct 22, 2026

Technical
55
Fundamental
41
News
52

The reading

SELLAS Life Sciences Group (SLS) scores 48 out of 100, which reads weak, higher than 57% of Healthcare stocks and 36% of the 4,161 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 55, fundamentals 41.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Quality (Annual) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 51 and contrarian oscillators 48.

News sentiment is neutral at 52; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 45 to 69, and it is down 8 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward SLS’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

41

Pulling it up

  • Quick Ratio100

    Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Current Ratio100

    Current ratio measures ability to pay short-term liabilities with current assets.

Holding it back

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

  • Earnings Growth (5-Year)0

    5-year earnings growth evaluates long-term profit trajectory and consistency.

  • Return on Equity (ROE)0

    Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.

29 weighted scorers; 12 had no data today and are left out rather than counted as zero.

Technical · daily

52

Pulling it up

  • 52-Week Change100

    The price change over the last 52 weeks.

  • S&P 500 52W Comparison100

    S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.

  • SMA 20098

    Simple Moving Average (200-period) is the most widely followed long-term trend indicator.

Holding it back

  • Ichimoku Cloud0

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • Parabolic SAR (PSAR)0

    Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • SMA 50 Cross Up7

    SMA 50 Cross Up detects when faster averages cross above the 50-period SMA.

61 weighted scorers; 4 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
52

Technical score by timeframe

ChartScoreWeight
Hourly391
Daily523
Weekly662
Monthly552
Quarterly552

Composite score, last 90 days

05010048Jul 25, 2026Oct 22, 2026Jul 25, 2026: 56Jul 26, 2026: 56Jul 27, 2026: 55Jul 28, 2026: 54Jul 29, 2026: 66Jul 30, 2026: 67Jul 31, 2026: 69Aug 2, 2026: 51Aug 3, 2026: 53Aug 5, 2026: 55Aug 6, 2026: 54Aug 7, 2026: 55Aug 8, 2026: 55Aug 9, 2026: 55Aug 10, 2026: 52Aug 11, 2026: 51Aug 12, 2026: 54Aug 13, 2026: 55Aug 14, 2026: 55Aug 15, 2026: 55Aug 16, 2026: 55Aug 17, 2026: 55Aug 18, 2026: 55Aug 19, 2026: 56Aug 20, 2026: 55Aug 22, 2026: 54Aug 23, 2026: 54Aug 24, 2026: 53Aug 25, 2026: 53Aug 26, 2026: 52Aug 27, 2026: 54Aug 28, 2026: 52Aug 29, 2026: 52Aug 30, 2026: 52Aug 31, 2026: 51Sep 1, 2026: 51Sep 2, 2026: 53Sep 3, 2026: 54Sep 4, 2026: 52Sep 5, 2026: 53Sep 6, 2026: 53Sep 7, 2026: 53Sep 8, 2026: 54Sep 9, 2026: 52Sep 10, 2026: 50Sep 11, 2026: 47Sep 12, 2026: 48Sep 13, 2026: 48Sep 14, 2026: 48Sep 15, 2026: 47Sep 16, 2026: 48Sep 17, 2026: 48Sep 18, 2026: 48Sep 19, 2026: 49Sep 20, 2026: 49Sep 21, 2026: 48Sep 22, 2026: 50Sep 23, 2026: 48Sep 24, 2026: 49Sep 25, 2026: 49Sep 26, 2026: 49Sep 27, 2026: 49Sep 28, 2026: 48Sep 29, 2026: 48Sep 30, 2026: 51Oct 1, 2026: 48Oct 2, 2026: 49Oct 3, 2026: 49Oct 4, 2026: 49Oct 5, 2026: 49Oct 6, 2026: 48Oct 7, 2026: 48Oct 8, 2026: 47Oct 9, 2026: 50Oct 10, 2026: 50Oct 11, 2026: 50Oct 12, 2026: 51Oct 13, 2026: 52Oct 14, 2026: 50Oct 15, 2026: 47Oct 16, 2026: 45Oct 17, 2026: 45Oct 18, 2026: 45Oct 19, 2026: 46Oct 20, 2026: 49Oct 21, 2026: 51Oct 22, 2026: 48
Show the daily numbers
DateComposite
Oct 22, 202648
Oct 21, 202651
Oct 20, 202649
Oct 19, 202646
Oct 18, 202645
Oct 17, 202645
Oct 16, 202645
Oct 15, 202647
Oct 14, 202650
Oct 13, 202652
Oct 12, 202651
Oct 11, 202650
Oct 10, 202650
Oct 9, 202650
Oct 8, 202647
Oct 7, 202648
Oct 6, 202648
Oct 5, 202649
Oct 4, 202649
Oct 3, 202649
Oct 2, 202649
Oct 1, 202648
Sep 30, 202651
Sep 29, 202648
Sep 28, 202648
Sep 27, 202649
Sep 26, 202649
Sep 25, 202649
Sep 24, 202649
Sep 23, 202648
Sep 22, 202650
Sep 21, 202648
Sep 20, 202649
Sep 19, 202649
Sep 18, 202648
Sep 17, 202648
Sep 16, 202648
Sep 15, 202647
Sep 14, 202648
Sep 13, 202648
Sep 12, 202648
Sep 11, 202647
Sep 10, 202650
Sep 9, 202652
Sep 8, 202654
Sep 7, 202653
Sep 6, 202653
Sep 5, 202653
Sep 4, 202652
Sep 3, 202654
Sep 2, 202653
Sep 1, 202651
Aug 31, 202651
Aug 30, 202652
Aug 29, 202652
Aug 28, 202652
Aug 27, 202654
Aug 26, 202652
Aug 25, 202653
Aug 24, 202653
Aug 23, 202654
Aug 22, 202654
Aug 20, 202655
Aug 19, 202656
Aug 18, 202655
Aug 17, 202655
Aug 16, 202655
Aug 15, 202655
Aug 14, 202655
Aug 13, 202655
Aug 12, 202654
Aug 11, 202651
Aug 10, 202652
Aug 9, 202655
Aug 8, 202655
Aug 7, 202655
Aug 6, 202654
Aug 5, 202655
Aug 3, 202653
Aug 2, 202651
Jul 31, 202669
Jul 30, 202667
Jul 29, 202666
Jul 28, 202654
Jul 27, 202655
Jul 26, 202656
Jul 25, 202656

Key facts

Market cap
$2.3B
Sector
Healthcare
Industry
Biotechnology
Beta
2.57
Risk grade (1–10)
6
Next earnings
Nov 11, 2026

Biotechnology peers

CompanyMarket capScore
AUPH Aurinia Pharmaceuticals$2.3B76
PGEN Precigen$2.3B46
CLDX Celldex Therapeutics$2.3B30
FTRE Fortrea$2.3B52
AGIO Agios Pharmaceuticals$2.2B49
BHVN Biohaven$2.2B43

Questions

What is SLS's stock score today?

SLS scores 48/100 (Weak) as of Oct 22, 2026: technical 55, fundamental 41, and news sentiment 52, which is shown but not counted. Scores are recomputed every night.

Is SLS a buy?

The score is not a buy or sell recommendation. A 48 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the SLS score calculated?

90 weighted scorers feed it today: 29 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.